Monthly Communication Report

Corporation:	AstraZeneca Canada Inc.
Associated registration:	957438-15042-61
Communication date:	2025-05-28
Posted date:	2025-06-16

Designated Public Office Holders who participated in the communication:	Cynthia Colapinto, Director, Policy and Data Division Health Product Shortages Directorate, Health Canada (HC) Ursula Polack, Senior Advisor Health Product Shortages Directorate, Health Canada (HC)
List of Details Subject matter Detail Health, International Development, Research and Development Regulations, policies and programs related to the review and reimbursement processes of Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance.
Responsible Officer who filed this communication report:	Gaby Bourbara
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.